These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 23402235

  • 1. [Extensive thromboembolism after cardioversion in a patient treated with dabigatran].
    Buch TN, Holm J, Munck LK.
    Ugeskr Laeger; 2013 Feb 04; 175(6):333-4. PubMed ID: 23402235
    [Abstract] [Full Text] [Related]

  • 2. Coronary embolization following electrical cardioversion in a patient treated with dabigatran.
    Gagliardi L, Guerbaai RA, Marlière S, Bouvaist H, Ennezat PV.
    Int J Cardiol; 2014 Aug 20; 175(3):571-2. PubMed ID: 24861253
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Acute ischemic stroke following cardioversion in a patient receiving dabigatran.
    Faust AC, Smith MB, Kawalsky D.
    Ann Pharmacother; 2013 Oct 20; 47(10):1368-71. PubMed ID: 24259703
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. What is the role of renal replacement therapy in the setting of dabigatran toxicity?
    Ghannoum M, Nolin TD.
    Semin Dial; 2014 Oct 20; 27(3):223-6. PubMed ID: 24620942
    [No Abstract] [Full Text] [Related]

  • 8. Dabigatran-induced acute hepatitis.
    Rochwerg B, Xenodemetropoulos T, Crowther M, Spyropoulos A.
    Clin Appl Thromb Hemost; 2012 Sep 20; 18(5):549-50. PubMed ID: 22962308
    [No Abstract] [Full Text] [Related]

  • 9. [Effective, safe stroke prevention with novel oral anticoagulants in patients with atrial fibrillation. Focus on dabigatran].
    Szapary L, Fehér G, Bosnyák E, Deli G, Csécsei P.
    Ideggyogy Sz; 2013 May 30; 66(5-6):165-74. PubMed ID: 23909016
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Modeling of the impact on health outcomes of the use of dabigatran in patients with atrial fibrillation.
    Chevalier J, Giroud M, de Pouvourville G.
    Cerebrovasc Dis; 2013 May 30; 35(4):320-6. PubMed ID: 23615428
    [Abstract] [Full Text] [Related]

  • 13. Implications of Dabigatran, a direct thrombin inhibitor, for oral surgery practice.
    Davis C, Robertson C, Shivakumar S, Lee M.
    J Can Dent Assoc; 2013 May 30; 79():d74. PubMed ID: 23920075
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Gastrointestinal bleeding under dabigatran.
    Stöllberger C, Lindner K, Finsterer J.
    J Postgrad Med; 2014 May 30; 60(2):192-3. PubMed ID: 24823522
    [Abstract] [Full Text] [Related]

  • 16. Is there really misuse and abuse of dabigatran?
    Eikelboom JW, Hankey GJ.
    Med J Aust; 2013 Apr 15; 198(7):358-9. PubMed ID: 23581946
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Dabigatran, electrical cardioversion and measuring the aPTT. A safety measure or an unnecessary assessment?
    Rahmat N, Khan A.
    BMJ Case Rep; 2013 Jun 19; 2013():. PubMed ID: 23784770
    [Abstract] [Full Text] [Related]

  • 20. Dabigatran-induced esophagitis.
    Ootani A, Hayashi Y, Miyagi Y.
    Clin Gastroenterol Hepatol; 2014 Jul 19; 12(7):e55-6. PubMed ID: 24036049
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.